BeyondSpring Pharmaceuticals, Inc (BeyondSpring)

Oncology Corporate Profile

HQ Location

48 Wall Street, 11th Floor
New York, NY 10005

Company Description

BeyondSpring Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies. BeyondSpring is focused on the advancement and commercialization of Plinabulin, a novel, Phase 3-ready cancer therapeutic initially targeting non-small-cell lung cancer (NSCLC).


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
plinabuin (+ docetaxel)synthetic analogueNon Small Cell Lung Cancer (NSCLC)III
plinabuin (+ nivolumab)synthetic analogueNon Small Cell Lung Cancer (NSCLC)I
plinabuin (+ radiation)synthetic analogueGliomaPreclinical
plinabuin (+ docetaxel)synthetic analogueKRAS Mutant Non Small Cell Lung Cancer (NSCLC)Preclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display